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DOI: 10.1016/j.ajpath.2011.11.004This Month in AJPAlcohol, Edema, and Traumatic Brain Injury
While the role of ethanol consumption prior to traumatic
brain injury (TBI) in aggravating morbidity and mortality
remains controversial, the negative effects of brain
edema are well established. Katada et al (Am J Pathol
2012, 180:17–23) hypothesized that TBI-related brain
edema is significantly potentiated by ethanol-induced ex-
pression of the water channel aquaporin-4 (AQP4). In rats
acute ethanol administration increased AQP4 expression
after TBI, leading to severe brain edema. Ethanol pre-
treatment induced lipid peroxidation as well as expres-
sion of NF-B and hypoxia-inducible factor-1 after TBI.
An AQ4 inhibitor (acetazolamide) improved the survival
rate to 100% and decreased brain edema and AQP4
expression. These data suggest that AQP4 inhibition may
reduce morbidity and mortality in alcohol-intoxicated TBI
patients as well as in those with ischemic brain injury or
brain tumor edema.
Renal DCs in Tubulointerstitial Damage and
Fibrosis
Renal dendritic cells (DCs), which may participate in local
inflammation, exist in heterogeneous populations that share
surface marker overlap with monocytes/macrophages. Us-
ing unilateral ureteral obstruction (UUO) as a model inflam-
matory disease, Snelgrove et al (Am J Pathol 2012, 180:91–
103) sought to define the role of DCs in the kidney. Renal
DCs underwent morphological and functional changes (in-
creased CD11b and less F4/80 expression) in the injured
kidney, consistent with a pro-inflammatory phenotype. The
low capacity of renal DCs to induce T-cell proliferation was
increased in the UUO inflammatory milieu. Depletion stud-
ies showed that although renal CD11c cells became ac-
tivated, renal DCs did not directly contribute to apoptosis or
fibrosis in the early stages after UUO. In the context of
interstitial inflammation, renal DCs function more effectively
as antigen-presenting cells than as contributors to tubulo-
interstitial damage and fibrosis.
Th17 Cells Express Histamine H4 Receptor
The histamine H4 receptor (H4R) is functionally ex-
pressed on Th2-polarized CD4 T cells. IL-17–producing
T cells (Th17 cells), another CD4 T-cell subset, are
found in psoriatic plaques and in acute skin lesions of
atopic dermatitis where histamine is also present in high
concentrations. Mommert et al (Am J Pathol 2012, 180:
177–185) examined the role H4R on Th17 cells. In vitro
activated Th17 cells expressed H4R mRNA and protein.IL-17–positive cells from psoriatic skin lesions were also
positive for functional H4R, and stimulation with histamine
or an H4R agonist increased IL-17 production and in-
duced activating protein-1 in Th17 cells. Thus, histamine
might foster the immunomodulatory potency of skin-infil-
trating Th17 cells in inflammatory skin diseases such as
psoriasis and atopic dermatitis.
Understanding the Molecular Mechanisms of
Dementia
In several neurodegenerative disorders, pathological
TDP-43 mislocalizes from its nuclear location to the cyto-
plasm, where it is proteolytically cleaved to form C-termi-
nal fragments. Caccamo et al (Am J Pathol 2012, 180:
293–302) examined the 25-kDa C-terminal fragment of
TDP-43 (TDP-25) to discern its role in disease pathogen-
esis. Transgenic mice expressing TDP-25 developed
cognitive deficits associated with the build-up of soluble
TDP-25. These cognitive deficits were independent of TDP-
43–positive inclusions, occurring without overt neurodegen-
eration. Additionally, TDP-25 expression was sufficient to
alter the processing of endogenous full-length TDP-43.
These data provide a framework for understanding the mo-
lecular mechanisms underlying the onset of cognitive defi-
cits in TDP-43 proteinopathies, such as frontotemporal lobar
degeneration cases (FTLD-TDP), motor neuron disease,
and amyotrophic lateral sclerosis.
Drug-Resistant Dormancy in Cancer
Tumor recurrence from remnant tumor cells presents an
important challenge to the success of cancer chemother-
apy, with drug-resistant cells persisting and sustaining
the tumor or entering dormancy before igniting a future
relapse. Kinoshita et al (Am J Pathol 2012, 180:375–389)
examined the mechanisms of such relapse in cultured
high-grade ovarian carcinoma cells. Partial knockdown of
nucleoporin p62 (NUP62; of the nuclear pore complex)
by small-interfering RNA conferred cisplatin resistance.
Treatment with NUP62 small-interfering RNA and cispla-
tin left resistant cells in a state of dormancy; some dor-
mant cells could be induced to proliferate by transient
induction of NUP62 expression from an ectopic expres-
sion construct. The modulation of nuclear pore architec-
ture represents a novel mechanism through which tumor
cells could acquire transient resistance to certain chemo-
therapeutic agents, and the culture system provides a
novel experimental window into the dynamics of tumor
cell drug resistance and dormancy.
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